[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
September 23, 1899


JAMA. 1899;XXXIII(13):799-800. doi:10.1001/jama.1899.02450650049010

This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.


The new remedy, to be of value to the busy practitioner, must be accompanied by the report of careful studies as to its mode of action and its therapeutic indications. Who shall furnish this? The pharmacologists alone after painstaking experiment may authoritatively report on the physiologic action of the new product. These are not numerous, and, excepting a few now finding a place in the schools, can hardly thrive beyond the confines of the laboratories of the great manufacturing pharmacists. As a rule the profession may safely rely for pharmacologic information on the reports of the experimenters employed by the large manufacturers. In the future, however, the laboratories of the schools will contribute largely to unbiased pharmacology. The physician with an extensive hospital service is best able to effectively determine the therapeutic value of the new drug. It is the rule to look askance on the laudatory clinical report from

First Page Preview View Large
First page PDF preview
First page PDF preview